Tag Archives: Sam Eskandari

Veritas Pharma

Veritas Pharma Enters into Agreement to Secure ACMPR License and Cannabis Growing Facility

Veritas Pharma Enters into Agreement to Secure ACMPR License and Cannabis Growing Facility

VANCOUVER, British Columbia, Nov. 21, 2016 /Weed Wire/ — Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), (“Veritas” or the “Company”), an emerging-stage pharmaceutical and IP development company, is pleased to announce that it has signed a Letter of Intent (“LOI”) with Sechelt Organic Marijuana Inc.

Veritas Pharma

Veritas Reaches Important Scientific Milestone; Animal Studies Fully Underway to Evaluate the Safety and Effectiveness of Cannabis Strains

VANCOUVER, Aug. 10, 2016 /Weed Wire/ — Veritas Pharma Inc. announced the Company has initiated its crucial next phase of research and development, commencing functional pharmacological evaluations in rodents related to multiple cannabis strains.

Veritas Pharma

Veritas Pharma Embarks on Important Next Phase of Cannabis Research

VANCOUVER, Aug. 3, 2016 /Weed Wire/ — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) is pleased to announce that through Cannevert Therapeutics Ltd, Veritas’ research arm, has developed several candidate cannabis strains and is now fully engaged in chemical and biological assessment of these key strains.

Veritas Pharma

Veritas Lists and Increases Private Placement on Bay Street Cannabis Web Portal

VANCOUVER, British Columbia, March 30, 2016 /Weed Wire/ — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:2VP) announces that the Company’s previously announced private placement has been listed on the newly created online investment platform, Bay Street Cannabis.


Top